Immunogen (IMGN) Tops Q2 EPS by 3c
Tweet
Share
E-mailGet Alerts IMGN Hot Sheet
Price: $31.25 --0%
Financial Fact:
Other (expense) income, net: 129K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Other (expense) income, net: 129K
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Immunogen (NASDAQ: IMGN) reported Q2 EPS of ($0.15), $0.03 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $16.94 million versus the consensus estimate of $18.92 million.
GUIDANCE:
Immunogen sees FY2021 revenue of $65-75 million, versus the consensus of $69.33 million.
For earnings history and earnings-related data on Immunogen (IMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Lument Finance Trust (LFT) Misses Q2 EPS by 17c
- CaliberCos Inc (CWD) Misses Q2 EPS by 43c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
